Patent US4664906A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4664906A Expired / Lapsed US ⏱️ 0.0 years remaining

Oral compositions

Assignee: Johnson and Johnson Consumer Inc
•
Filing: 1984-08-30
•
Granted: 1987-05-12
•
Expires: 2004-08-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Oral compositions which exhibit antimicrobial activity containing hexedine and a pharmaceutically acceptable zinc compound.

Inventors

  • 👤 Tibor Sipos

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:21
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61K8/494; A61K8/4946; A61K8/19; A61K8/27; A61Q; A61Q11/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 78 words
An oral composition comprising a pharmaceutically-acceptable vehicle containing from about 0.0025 to about 2.0% by weight of hexedine and from about 0.01 to about 25.0% by weight of a pharmaceutically-acceptable zinc salt selected from the group consisting of zinc chloride, zinc sulfate, zinc citrate, zinc acetate, zinc lactate, zinc salicylate, zinc thiocyanate, zinc gluconoheptanoate, zinc gluconate, zinc maleate, and zinc fumarate wherein the hexedine and zinc are present in a weight ratio of from about 1:1 to 1:32.
Claim 2
Dependent Claim 78 words
An oral composition comprising a pharmaceutically-acceptable vehicle containing from about 0.0025 to about 2.0% by weight of hexedine and from about 0.01 to about 25.0% by weight of a pharmaceutically-acceptable zinc salt selected from the group consisting of zinc chloride, zinc sulfate, zinc citrate, zinc acetate, zinc lactate, zinc salicylate, zinc thiocyanate, zinc gluconoheptanoate, zinc gluconate, zinc maleate, and zinc fumarate wherein the hexedine and zinc are present in a weight ratio of from about 1:1 to 1:32.
Claim 3
Dependent Claim 21 words
The composition of claim 1 wherein hexedine is present in a concentration of from about 0.05 to about 1.0% by weight.
Claim 4
Dependent Claim 21 words
The composition of claim 1 wherein hexedine is present in a concentration of from about 0.05 to about 0.2% by weight.
Claim 5
Dependent Claim 22 words
The composition of claim 1 wherein the zinc ion is present in a concentration of from about 0.05 to 4.0% by weight.
Claim 6
Dependent Claim 28 words
The composition of claim 1 wherein said vehicle comprises at least one member selected from the group consisting of glycerol, water, ethanol, polyethylene glycol, propylene glycol and sorbitol.
Claim 7
Dependent Claim 33 words
A method of preventing or reducing the incidence of gingivitis comprising applying to the teeth and gingavae of the subject to be treated a therapeutically effective amount of the composition of claim 1.
Claim 8
Dependent Claim 14 words
The method of claim 6 wherein said composition is applied at least once daily.
Claim 9
Dependent Claim 12 words
The method of claim 6 wherein said composition is applied twice daily.

References Cited (Backward Citations)

US2393826A Cited
FR4501M Cited
US3357886A Cited
US3888976A Cited
US4022880A Cited
US4146607A Cited
US4160821A Cited
US4395398A Cited
US4406881A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-11 1990-11-10 1991-05-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-11 1994-11-10 1995-05-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-11 1998-11-10 1999-05-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag